Daniela Di Giuseppe
Overview
Explore the profile of Daniela Di Giuseppe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1039
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polysopoulos C, Georgiadis S, Ornbjerg L, Scherer A, Di Giuseppe D, Hetland M, et al.
BMC Med Res Methodol
. 2025 Feb;
25(1):55.
PMID: 40021967
Background: Observational data on composite scores often comes with missing component information. When a complete-case (CC) analysis of composite scores is unbiased, preferable approaches of dealing with missing component information...
2.
Georgiadis S, Pons M, Rasmussen S, Hetland M, Linde L, Di Giuseppe D, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39979039
Objectives: We aimed to compare various methods for imputing disease activity in longitudinally collected observational data of patients with axial spondyloarthritis (axSpA). Methods: We conducted a simulation study on data...
3.
Pons M, Georgiadis S, Hetland M, Faizy Ahmadzay Z, Rasmussen S, Christiansen S, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892891
Objective: In patients with axial spondyloarthritis (axSpA) initiating secukinumab (SEC), we aimed to identify baseline (treatment start) predictors of achieving low disease activity (LDA) after 6 months, as measured by...
4.
Ahmadzay Z, Heberg J, Jorgensen J, Ornbjerg L, Ostergaard M, Moller-Bisgaard S, et al.
Rheumatol Adv Pract
. 2024 Nov;
8(4):rkae135.
PMID: 39611201
Objectives: Real-world evidence is needed to inform treatment strategies for patients with PsA and axial SpA (axSpA) who have non-musculoskeletal manifestations (NMMs), various risk factors and comorbidities. International collaboration is...
5.
Edstorp J, Rossides M, Ahlqvist E, Alfredsson L, Askling J, Di Giuseppe D, et al.
Diabetologia
. 2024 Oct;
68(1):69-81.
PMID: 39467872
Aims/hypothesis: Some studies find an increased risk of type 1 diabetes in children exposed to antibiotics. We investigated if exposure to antibiotics increases the risk of latent autoimmune diabetes in...
6.
Eberhard A, Di Giuseppe D, Askling J, Bergman S, Bower H, Chatzidionysiou K, et al.
Arthritis Rheumatol
. 2024 Sep;
77(3):253-262.
PMID: 39308007
Objective: To compare the effectiveness of JAK inhibitors (JAKis) and biologic disease-modifying antirheumatic drugs (bDMARDs) on pain in patients with rheumatoid arthritis. Methods: In this retrospective study, we investigated patients...
7.
Exarchou S, Di Giuseppe D, Klingberg E, Sigurdardottir V, Wedren S, Lindstrom U, et al.
J Rheumatol
. 2024 Sep;
52(1):38-46.
PMID: 39278652
Objective: Prior incidence estimates of psoriatic arthritis (PsA) vary considerably. We aimed to assess the annual incidence of clinically diagnosed PsA among adults in Sweden in 2014-2016, overall and stratified...
8.
Provan S, Ljung L, Kristianslund E, Michelsen B, Uhlig T, Jonmundsson T, et al.
J Rheumatol
. 2024 Sep;
51(11):1111-1118.
PMID: 39218450
Objective: Interstitial lung disease (ILD) is one of the most common pulmonary manifestations of rheumatoid arthritis (RA), but its prevalence has not been investigated in psoriatic arthritis (PsA). The role...
9.
Christiansen S, Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, et al.
RMD Open
. 2024 Jul;
10(3.
PMID: 39053949
Objectives: To compare the treatment effectiveness of secukinumab in radiographic (r) versus non-radiographic (nr) axial spondyloarthritis (axSpA) patients treated in routine care across Europe. Methods: Prospectively collected data on secukinumab-treated...
10.
Linde L, Georgiadis S, Ornbjerg L, Rasmussen S, Michelsen B, Askling J, et al.
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(11):1558-1565.
PMID: 38926900
Objective: Because 66/68 joint counts are not always performed in routine care, we aimed to determine which of the modified 28-joint disease activity index for psoriatic arthritis (DAPSA28) or 28-joint...